Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
IOSP · 10-Q filed May 8, 2026

IOSP earnings analysis

What we found in IOSP's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Innospec (IOSP) reported strong Q1 2026 performance, exceeding estimates with revenue of $453.2 million and EPS of $1.05. Both metrics showed year-over-year growth partly driven by strong Fuel Specialties sales despite adverse weather impacts on Performance Chemicals. The company anticipates continued sequential growth in the coming quarter, though it faces some challenges related to operating expenses and foreign exchange rates.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue Growth Exceeds Estimates
Q1 2026 revenue reached $453.2 million, a 3% increase from $440.8 million in Q1 2025, surpassing estimates by 4.87%.
Positive EPS Surprise
Reported EPS for Q1 2026 stood at $1.05, exceeding the estimate of $1.01, reflecting a surprise of 3.96%.
Fuel Specialties Segment Up 7%
Fuel Specialties revenue increased to $181.6 million in Q1 2026, up from $170.3 million in Q1 2025, representing a 7% growth.
Cash Generation from Operations
Operating cash flow was $17.6 million for Q1 2026, albeit down from $28.3 million in Q1 2025.
Stable Cash Position
Cash and cash equivalents remained relatively stable at $289.1 million as of March 31, 2026, compared to $292.5 million at year-end 2025.
Adjusted Working Capital Increased
Adjusted working capital rose by $20.1 million compared to the previous quarter, resulting in a total adjusted working capital of $384.8 million.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Decreased Gross Profit
Gross profit declined to $123.5 million in Q1 2026 from $125.1 million in Q1 2025, a decrease of 1.3%.
Increased Corporate Costs
Corporate costs rose by 26% year-over-year to $22.3 million, reflecting higher legacy costs and legal expenses.
Negative Impact from Winter Weather
Performance Chemicals segment saw net sales of $169.4 million, a marginal increase but significantly impacted by 15% lower volumes due to winter weather disruptions.
The numbers

What they reported.

What the company itself reported, taken out of the document.

What survived to operating profit
Of every $100 of revenue Cost of sales $73 Operating expenses $19 Left as operating profit $8
Percentages of revenue, taken from the filing. Drawn this way because it holds whatever scale the company reports in.
Earnings per share
$1.05
Gross margin
27.3%
Operating margin
8.1%
Segment
Performance Chemicals
Segment
Fuel Specialties
Segment
Oilfield Services
Guidance

What they said about what is next.

Company expressed optimism for sequential growth in Q2 2026, but specific guidance figures were not provided.

How we read the filing overall

The filing reads better than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-K · February 18, 2026
Innospec’s 2025 Form 10-K emphasizes a three-segment specialty chemicals strategy (Performance Chemicals, Fuel Specialties, Oilfield Services) focused on new product development, selective M&A and geographic expansion.…
10-Q · November 5, 2025
Innospec’s Q3 2025 results showed revenue essentially flat at $441.9 million (Q3 2024: $443.4M) but operating profit and EPS collapsed due to non‑recurring and impairment charges. The company recorded impairments of…
10-Q · May 9, 2025
Innospec reported Q1 net sales of $440.8 million (Q1 2024: $500.2M), with gross profit of $125.1 million and net income of $32.8 million. Revenue and margins contracted year-over-year; operating cash flow weakened to…
10-K · February 19, 2025
Innospec continues to position itself as a focused specialty chemicals group operating three reportable segments (Performance Chemicals, Fuel Specialties and Oilfield Services) and is investing in R&D and selective M&A…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing IOSP makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever